Lopes, C.F.; Laurent, E.; Caul-Futy, M.; Dubois, J.; Mialon, C.; Chojnacki, C.; Sage, E.; Boda, B.; Huang, S.; Rosa-Calatrava, M.;
et al. A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening. Microorganisms 2025, 13, 572.
https://doi.org/10.3390/microorganisms13030572
AMA Style
Lopes CF, Laurent E, Caul-Futy M, Dubois J, Mialon C, Chojnacki C, Sage E, Boda B, Huang S, Rosa-Calatrava M,
et al. A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening. Microorganisms. 2025; 13(3):572.
https://doi.org/10.3390/microorganisms13030572
Chicago/Turabian Style
Lopes, Cindia Ferreira, Emilie Laurent, Mireille Caul-Futy, Julia Dubois, Chloé Mialon, Caroline Chojnacki, Edouard Sage, Bernadett Boda, Song Huang, Manuel Rosa-Calatrava,
and et al. 2025. "A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening" Microorganisms 13, no. 3: 572.
https://doi.org/10.3390/microorganisms13030572
APA Style
Lopes, C. F., Laurent, E., Caul-Futy, M., Dubois, J., Mialon, C., Chojnacki, C., Sage, E., Boda, B., Huang, S., Rosa-Calatrava, M., & Constant, S.
(2025). A Novel In Vitro Primary Human Alveolar Model (AlveolAir™) for H1N1 and SARS-CoV-2 Infection and Antiviral Screening. Microorganisms, 13(3), 572.
https://doi.org/10.3390/microorganisms13030572